Your browser doesn't support javascript.
loading
Rabies virus vaccine as an immune adjuvant against cancers and glioblastoma: new studies may resurrect a neglected potential
Altinoz, MA; Guloksuz, S; Elmaci, I.
Affiliation
  • Altinoz, MA; Neuro-Academy Research Group. Istanbul. Turkey
  • Guloksuz, S; Maastricht University Medical Centre. Department of Psychiatry and Psychology. Maastricht. The Netherlands
  • Elmaci, I; Memorial Hospital. Department of Neurosurgery. Istanbul. Turkey
Clin. transl. oncol. (Print) ; 19(7): 785-792, jul. 2017.
Article in English | IBECS | ID: ibc-163433
Responsible library: ES1.1
Localization: BNCS
ABSTRACT
To review the literature about the use of Rabies Virus-Vaccine (RV-V) as an anticancer immunotherapeutic modality in the light of recent findings. The literature search in relevant databases with the following key words Rabies virus, cancer, remission. Remissions occured following RV-V injections in patients with cervical cancer and melanoma. Pilot clinical studies showed that RV-V injections enhanced survival in glioblastoma patients, which is supported by findings in GL261 mouse glioma model. If public health studies demonstrate protective role of RV-V against certain types of cancers, it can be benefitted as a novel immune adjuvant in clinic (AU)
RESUMEN
No disponible
Subject(s)
Search on Google
Add to My VHL
Print
XML

Collection: National databases / Spain Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being / Neglected Diseases Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.3: End transmission of communicable diseases / Target 3.4: Reduce premature mortality due to noncommunicable diseases / Neglected Diseases / Zoonoses Database: IBECS Main subject: Rabies Vaccines / Glioblastoma / Immunotherapy / Neoplasm Regression, Spontaneous Type of study: Prognostic study Limits: Humans Language: English Journal: Clin. transl. oncol. (Print) Year: 2017 Document type: Article Institution/Affiliation country: Maastricht University Medical Centre/The Netherlands / Memorial Hospital/Turkey / Neuro-Academy Research Group/Turkey
Search on Google
Add to My VHL
Print
XML

Collection: National databases / Spain Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being / Neglected Diseases Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.3: End transmission of communicable diseases / Target 3.4: Reduce premature mortality due to noncommunicable diseases / Neglected Diseases / Zoonoses Database: IBECS Main subject: Rabies Vaccines / Glioblastoma / Immunotherapy / Neoplasm Regression, Spontaneous Type of study: Prognostic study Limits: Humans Language: English Journal: Clin. transl. oncol. (Print) Year: 2017 Document type: Article Institution/Affiliation country: Maastricht University Medical Centre/The Netherlands / Memorial Hospital/Turkey / Neuro-Academy Research Group/Turkey